| Accounting Policies, by Policy (Policies) | 12 Months Ended |
| Jun. 30, 2023 |
| Accounting Policies [Abstract] | |
| New or amended Accounting Standards and Interpretations adopted | New or amended Accounting Standards and Interpretations
adopted The consolidated entity has adopted all of the
new or amended Accounting Standards and Interpretations issued by the Australian Accounting Standards Board (‘AASB’) that are mandatory
for the current reporting period. Any new or amended Accounting Standards or Interpretations
that are not yet mandatory have not been early adopted. |
| Basis of preparation | Basis of preparation These general purpose financial statements have
been prepared in accordance with Australian Accounting Standards and Interpretations issued by the Australian Accounting Standards Board
(‘AASB’) and the Corporations Act 2001, as appropriate for for-profit oriented entities. These financial statements also comply with International
Financial Reporting Standards as issued by the International Accounting Standards Board (‘IASB’). Historical cost convention The financial statements have been prepared under
the historical cost convention. Critical accounting estimates The preparation of the financial statements requires
the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the
consolidated entity’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions
and estimates are significant to the financial statements, are disclosed in note 2. Prior year comparatives This Annual Report uses comparatives sourced from
the Company’s re-issued 2022 Annual Report. The Annual Report was reissued on 14 December 2022. The reason for the reissue of the 2022 Annual
Report was announced in the AHI ASX Announcement dated 23 November 2022, in which it was advised that the Consolidated Entity will be
reissuing its 2022 Annual Report, following its subsequent material restatement of the fair value of its investment in Triage Technologies
Inc. (‘Triage Investment’) at 30 June 2022. This restatement followed the receipt of a formal valuation of the Consolidated Entity’s Triage
Investment by an accredited Canadian valuer, which increased the Consolidated Entity’s Net Asset position by $2,565,082 at 30 June 2022
and reduced its Total Comprehensive Loss by a corresponding amount for the year ended 30 June 2022. Where necessary, comparative information
has been reclassified for consistency with current year disclosures. |
| Going concern | Going concern These consolidated financial statements have been
prepared on the going concern basis which contemplates the continuity of normal business activities and the realisation of assets and
discharge of liabilities in the normal course of business. The consolidated entity
has incurred a net operating loss of $12,827,177 (2022: $20,076,843) which included non-cash items such as a provision for impairment
as well as share-based payments, has a net cash outflow from operating activities amounting to $7,367,184 (2022: $9,858,799) and a net
current asset deficiency of $2,776,308 as at 30 June 2023 (2022; surplus $4,912,968). Given the consolidated entity’s net current liability
position, the ability of the consolidated entity to continue as a going concern, including its ability to pay its debt as and when they
fall due, needs to be considered. The Directors are of the opinion that the continuation of the consolidated entity as a going concern
is dependent upon its ability to achieve the following:
● As announced on August 4, 2023, the Company executed a binding
exclusive, perpetual license with Shanghai-based Changlin Network Technology Ltd (“Changlin”). This agreement requires Changlin
to pay AHI USD$10 million within 90 days from the execution date for the exclusive and perpetual right to AHI’s technology.
● On 13 June 2023, The Company announced it had successfully
undertaken a $5,000,000 share placement with Orca Capital GMBH at a 194% premium to the last traded share price on Friday, 9 June 2023.
● As announced in its June 2023 Appendix 4C lodgement with
the ASX, the Company has been presented with three additional funding proposals between $5,000,000 and $20,000,000 through a placement
under its LR7.1 capacity. The Company is actively engaged in discussions with parties and anticipates closing the additional capital
soon.
● On 21 June 2023, the Company announced it had entered into
a Letter of Intention with UAE based e-script medicine management company Pharmak Pharmacy LLC to integrate AHI’s Biometric Health Assessment
into Pharmak’s e-script screening solution. The parties are targeting a January 2024 initial launch of the solution. Pharmak expects
to achieve a minimum e-script order volume in 2024 of 100,000 e-scripts per month in each of the UAE and Saudi Arabia. It has been agreed
between the parties that AHI will receive 1.6% of the gross e-script value. In addition to the above, the Company announced
on 13 September 2023 that it had secured a $1.5 million Convertible Loan facility as disclosed in note 38 and is also evaluating a number
of other financing proposals. The directors are confident
of the consolidated entity’s ability to achieve the above and have prepared the financial statements on a going concern basis as the directors
believe that the consolidated entity will be able to pay its debt as and when they fall due and payable. The financial statements
have been prepared on a going concern basis which assumes that the Group will realise its assets and extinguish its liabilities in the
normal course of business. In the event that the above arrangements and initiatives are not achieved, there exists a material uncertainty
as to whether the consolidated entity will continue as a going concern and, therefore, whether it will realise its assets and extinguish
its liabilities in the normal course of business and at the amounts stated in the financial statements. The financial statements do not
include any adjustments relating to the recoverability and classification of recorded asset amounts or to the amounts and classification
of liabilities that may be necessary should the consolidated entity not continue as a going concern. |
| Parent entity information | Parent entity information In accordance with the Corporations Act 2001,
these financial statements present the results of the consolidated entity only. Supplementary information about the parent entity is disclosed
in Note 40. |
| Principles of consolidation | Principles of consolidation The consolidated financial statements incorporate
the assets and liabilities of all subsidiaries of Advanced Health Intelligence Ltd (‘Company’ or ‘parent entity’) as at 30 June 2023 and
the results of all subsidiaries for the year then ended. Advanced Health Intelligence Ltd and its subsidiaries together are referred to
in these financial statements as the ‘consolidated entity’. Subsidiaries are all those entities over which
the consolidated entity has control. The consolidated entity controls an entity when the consolidated entity is exposed to, or has rights
to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the
activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the consolidated entity.
They are de-consolidated from the date that control ceases. Intercompany transactions, balances and unrealised
gains on transactions between entities in the consolidated entity are eliminated. Unrealised losses are also eliminated unless the transaction
provides evidence of the impairment of the asset transferred. Accounting policies of subsidiaries have been changed where necessary to
ensure consistency with the policies adopted by the consolidated entity. The acquisition of subsidiaries is accounted for
using the acquisition method of accounting. A change in ownership interest, without the loss of control, is accounted for as an equity
transaction, where the difference between the consideration transferred and the book value of the share of the non-controlling interest
acquired is recognised directly in equity attributable to the parent. Where the consolidated entity loses control over
a subsidiary, it derecognises the assets including goodwill, liabilities and non-controlling interest in the subsidiary together with
any cumulative translation differences recognised in equity. The consolidated entity recognises the fair value of the consideration received
and the fair value of any investment retained together with any gain or loss in profit or loss. |
| Operating segments | Operating segments Operating segments are presented using the ‘management
approach’, where the information presented is on the same basis as the internal reports provided to the Chief Operating Decision Makers
(‘CODM’). The CODM is responsible for the allocation of resources to operating segments and assessing their performance. |
| Foreign currency translation | Foreign currency translation The financial statements are presented in Australian
dollars, which is Advanced Health Intelligence Ltd’s functional and presentation currency. Foreign currency transactions Foreign currency transactions are translated into
Australian dollars using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from
the settlement of such transactions and from the translation at financial year-end exchange rates of monetary assets and liabilities denominated
in foreign currencies are recognised in profit or loss. Foreign operations The assets and liabilities of foreign operations
are translated into Australian dollars using the exchange rates at the reporting date. The revenues and expenses of foreign operations
are translated into Australian dollars using the average exchange rates, which approximate the rates at the dates of the transactions,
for the period. All resulting foreign exchange differences are recognised in other comprehensive income through the foreign currency reserve
in equity. The foreign currency reserve is recognised in
profit or loss when the foreign operation or net investment is disposed of. |
| Revenue recognition | Revenue recognition The consolidated entity recognises revenue as
follows: Revenue from contracts with customers Revenue is recognised at an amount that reflects
the consideration to which the consolidated entity is expected to be entitled in exchange for transferring goods or services to a customer.
For each contract with a customer, the consolidated entity: identifies the contract with a customer; identifies the performance obligations
in the contract; determines the transaction price which takes into account estimates of variable consideration and the time value of money;
allocates the transaction price to the separate performance obligations on the basis of the relative stand-alone selling price of each
distinct good or service to be delivered; and recognises revenue when or as each performance obligation is satisfied in a manner that
depicts the transfer to the customer of the goods or services promised. Variable consideration within the transaction
price, if any, reflects concessions provided to the customer such as discounts, rebates and refunds, any potential bonuses receivable
from the customer and any other contingent events. Such estimates are determined using either the ‘expected value’ or ‘most likely amount’
method. The measurement of variable consideration is subject to a constraining principle whereby revenue will only be recognised to the
extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur. The measurement
constraint continues until the uncertainty associated with the variable consideration is subsequently resolved. Amounts received that
are subject to the constraining principle are recognised as a refund liability. Sale of goods Revenue from the sale of goods is recognised at
the point in time when the customer obtains control of the goods, which is generally at the time of delivery. Software services Software services are comprised of recurring services
to customers. Software services revenue is measured based on the consideration specified in a contract with customers. The Company satisfies
its performance obligation, and revenue from these services is recognised, on a straight-line basis over the service period as the Company
provides the service to the customer. In certain arrangements, the Company receives payment before services have been performed. These
payments are initially recorded as deferred revenue and are recognised as revenue over the service period. Interest Interest revenue is recognised as interest accrues
using the effective interest method. This is a method of calculating the amortised cost of a financial asset and allocating the interest
income over the relevant period using the effective interest rate, which is the rate that exactly discounts estimated future cash receipts
through the expected life of the financial asset to the net carrying amount of the financial asset. Other revenue Other revenue is recognised when it is received
or when the right to receive payment is established. R&D Tax incentive – Grant R&D tax incentive
is recognised when it is received and is recognised as grant income. |
| Income tax | Income tax The income tax expense or benefit for the period
is the tax payable on that period’s taxable income based on the applicable income tax rate for each jurisdiction, adjusted by the changes
in deferred tax assets and liabilities attributable to temporary differences, unused tax losses and the adjustment recognised for prior
periods, where applicable. Deferred tax assets and liabilities are recognised
for temporary differences at the tax rates expected to be applied when the assets are recovered or liabilities are settled, based on those
tax rates that are enacted or substantively enacted, except for:
● When the deferred income tax asset or liability arises from
the initial recognition of goodwill or an asset or liability in a transaction that is not a business combination and that, at the time
of the transaction, affects neither the accounting nor taxable profits; or
● When the taxable temporary difference is associated with
interests in subsidiaries, associates or joint ventures, and the timing of the reversal can be controlled and it is probable that the
temporary difference will not reverse in the foreseeable future. Deferred tax assets are recognised for deductible
temporary differences and unused tax losses only if it is probable that future taxable amounts will be available to utilise those temporary
differences and losses. The carrying amount of recognised and unrecognised
deferred tax assets are reviewed at each reporting date. Deferred tax assets recognised are reduced to the extent that it is no longer
probable that future taxable profits will be available for the carrying amount to be recovered. Previously unrecognised deferred tax assets
are recognised to the extent that it is probable that there are future taxable profits available to recover the asset. Deferred tax assets and liabilities are offset
only where there is a legally enforceable right to offset current tax assets against current tax liabilities and deferred tax assets against
deferred tax liabilities; and they relate to the same taxable authority on either the same taxable entity or different taxable entities
which intend to settle simultaneously. |
| Current and non-current classification | Current and non-current classification Assets and liabilities are presented in the statement
of financial position based on current and non-current classification. An asset is classified as current when: it is
either expected to be realised or intended to be sold or consumed in the consolidated entity’s normal operating cycle; it is held primarily
for the purpose of trading; it is expected to be realised within 12 months after the reporting period; or the asset is cash or cash equivalent
unless restricted from being exchanged or used to settle a liability for at least 12 months after the reporting period. All other assets
are classified as non-current. A liability is classified as current when: it
is either expected to be settled in the consolidated entity’s normal operating cycle; it is held primarily for the purpose of trading;
it is due to be settled within 12 months after the reporting period; or there is no unconditional right to defer the settlement of the
liability for at least 12 months after the reporting period. All other liabilities are classified as non-current. Deferred tax assets and liabilities are always
classified as non-current. |
| Cash and cash equivalents | Cash and cash equivalents Cash and cash equivalents includes cash on hand,
deposits held at call with financial institutions, other short-term, highly liquid investments with original maturities of three months
or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. |
| Trade and other receivables | Trade and other receivables Trade receivables are initially recognised at
fair value and subsequently measured at amortised cost using the effective interest method, less any allowance for expected credit losses.
Trade receivables are generally due for settlement within 30 days. The consolidated entity has applied the simplified
approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure the expected credit losses, trade
receivables have been grouped based on days overdue. Other receivables are recognised at amortised
cost, less any allowance for expected credit losses. |
| Joint ventures | Joint ventures A joint venture is a joint arrangement whereby
the parties that have joint control of the arrangement have rights to the net assets of the arrangement. Investments in joint ventures
are accounted for using the equity method. Under the equity method, the share of the profits or losses of the joint venture is recognised
in profit or loss and the share of the movements in equity is recognised in other comprehensive income. Investments in joint ventures
are carried in the statement of financial position at cost plus post-acquisition changes in the consolidated entity’s share of net assets
of the joint venture. Goodwill relating to the joint venture is included in the carrying amount of the investment and is neither amortised
nor individually tested for impairment. Income earned from joint venture entities reduce the carrying amount of the investment. |
| Investments and Other Financial Assets | Investments and other financial assets Investments and other financial assets are initially
measured at fair value. Transaction costs are included as part of the initial measurement, except for financial assets at fair value through
profit or loss. Such assets are subsequently measured at either amortised cost or fair value depending on their classification. Classification
is determined based on both the business model within which such assets are held and the contractual cash flow characteristics of the
financial asset unless an accounting mismatch is being avoided. Financial assets are derecognised when the rights
to receive cash flows have expired or have been transferred and the consolidated entity has transferred substantially all the risks and
rewards of ownership. When there is no reasonable expectation of recovering part or all of a financial asset, its carrying value is written
off. Financial assets at fair value through profit or loss Financial assets not measured at amortised cost
or at fair value through other comprehensive income are classified as financial assets at fair value through profit or loss. Typically,
such financial assets will be either: (i) held for trading, where they are acquired for the purpose of selling in the short-term with
an intention of making a profit, or a derivative; or (ii) designated as such upon initial recognition where permitted. Fair value movements
are recognised in profit or loss. |
| Impairment of financial assets | Impairment of financial assets The consolidated entity recognises a loss allowance
for expected credit losses on financial assets which are either measured at amortised cost or fair value through other comprehensive income.
The measurement of the loss allowance depends upon the consolidated entity’s assessment at the end of each reporting period as to whether
the financial instrument’s credit risk has increased significantly since initial recognition, based on reasonable and supportable information
that is available, without undue cost or effort to obtain. Where there has not been a significant increase
in exposure to credit risk since initial recognition, a 12-month expected credit loss allowance is estimated. This represents a portion
of the asset’s lifetime expected credit losses that is attributable to a default event that is possible within the next 12 months. Where
a financial asset has become credit impaired or where it is determined that credit risk has increased significantly, the loss allowance
is based on the asset’s lifetime expected credit losses. The amount of expected credit loss recognised is measured on the basis of the
probability weighted present value of anticipated cash shortfalls over the life of the instrument discounted at the original effective
interest rate. For financial assets mandatorily measured at fair
value through other comprehensive income, the loss allowance is recognised in other comprehensive income with a corresponding expense
through profit or loss. In all other cases, the loss allowance reduces the asset’s carrying value with a corresponding expense through
profit or loss. |
| Description of accounting policy for property, plant and equipment [text block] | Property, plant and equipment Plant and equipment is stated at historical cost
less accumulated depreciation and impairment. Historical cost includes expenditure that is directly attributable to the acquisition of
the items. Depreciation is calculated on a straight-line
basis to write off the net cost of each item of property, plant and equipment (excluding land) over their expected useful lives as follows:
Office Equipment 3 - 5 years
Furniture & Fixtures 5 - 7 years The residual values, useful lives and depreciation
methods are reviewed, and adjusted if appropriate, at each reporting date. Leasehold improvements are depreciated over the
unexpired period of the lease or the estimated useful life of the assets, whichever is shorter. An item of property, plant and equipment is derecognised
upon disposal or when there is no future economic benefit to the consolidated entity. Gains and losses between the carrying amount and
the disposal proceeds are taken to profit or loss. |
| Right-of-use Assets | Right-of-use assets A right-of-use asset is recognised at the commencement
date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for,
as applicable, any lease payments made at or before the commencement date net of any lease incentives received, any initial direct costs
incurred, and, except where included in the cost of inventories, an estimate of costs expected to be incurred for dismantling and removing
the underlying asset, and restoring the site or asset. Right-of-use assets are depreciated on a straight-line
basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the consolidated
entity expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life.
Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities. The consolidated entity has elected not to recognise
a right-of-use asset and corresponding lease liability for short-term leases with terms of 12 months or less and leases of low-value assets.
Lease payments on these assets are expensed to profit or loss as incurred. |
| Intangible assets | Intangible assets Intangible assets acquired as part of a business
combination, other than goodwill, are initially measured at their fair value at the date of the acquisition. Intangible assets acquired
separately are initially recognised at cost. Indefinite life intangible assets are not amortised and are subsequently measured at cost
less any impairment. Finite life intangible assets are subsequently measured at cost less amortisation and any impairment. The gains or
losses recognised in profit or loss arising from the derecognition of intangible assets are measured as the difference between net disposal
proceeds and the carrying amount of the intangible asset. The method and useful lives of finite life intangible assets are reviewed annually.
Changes in the expected pattern of consumption or useful life are accounted for prospectively by changing the amortisation method or period. Goodwill Goodwill arises on the acquisition of a business.
Goodwill is not amortised. Instead, goodwill is tested annually for impairment, or more frequently if events or changes in circumstances
indicate that it might be impaired, and is carried at cost less accumulated impairment losses. Impairment losses on goodwill are taken
to profit or loss and are not subsequently reversed. Customer contracts Customer contracts acquired in a business combination
are amortised on a straight-line basis over the period of their expected benefit, being their finite life of 5 years. Software Significant costs associated with software are
deferred and amortised on a straight-line basis over the period of their expected benefit, being their finite life of 5 years. Application development Costs associated with
application development costs are amortised on a straight-line basis over the period of their expected benefit, being their finite life
of 5 years. |
| Impairment of non-financial assets | Impairment of non-financial assets Goodwill and other intangible assets that have
an indefinite useful life are not subject to amortisation and are tested annually for impairment, or more frequently if events or changes
in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes
in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognised for the amount by which the
asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s
fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating
to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not
have independent cash flows are grouped together to form a cash-generating unit. |
| Trade and other payables | Trade and other payables These amounts represent liabilities for goods
and services provided to the consolidated entity prior to the end of the financial year and which are unpaid. Due to their short-term
nature they are measured at amortised cost and are not discounted. The amounts are unsecured and are usually paid within 30 days of recognition. |
| Borrowings | Borrowings Loans and borrowings are initially recognised
at the fair value of the consideration received, net of transaction costs. They are subsequently measured at amortised cost using the
effective interest method. The component of the convertible notes that exhibits
characteristics of a liability is recognised as a liability in the statement of financial position, net of transaction costs. On the issue of the convertible notes the fair
value of the liability component is determined using a market rate for an equivalent non-convertible bond and this amount is carried as
a non-current liability on the amortised cost basis until extinguished on conversion or redemption. The increase in the liability due
to the passage of time is recognised as a finance cost. The remainder of the proceeds are allocated to the conversion option that is recognised
and included in shareholders equity as a convertible note reserve, net of transaction costs. The carrying amount of the conversion option
is not remeasured in the subsequent years. The corresponding interest on convertible notes is expensed to profit or loss. |
| Lease liabilities | Lease liabilities A lease liability is recognised at the commencement
date of a lease. The lease liability is initially recognised at the present value of the lease payments to be made over the term of the
lease, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the consolidated entity’s
incremental borrowing rate. Lease payments comprise of fixed payments less any lease incentives receivable, variable lease payments that
depend on an index or a rate, amounts expected to be paid under residual value guarantees, exercise price of a purchase option when the
exercise of the option is reasonably certain to occur, and any anticipated termination penalties. The variable lease payments that do
not depend on an index or a rate are expensed in the period in which they are incurred. Lease liabilities are measured at amortised cost
using the effective interest method. The carrying amounts are remeasured if there is a change in the following: future lease payments
arising from a change in an index or a rate used; residual guarantee; lease term; certainty of a purchase option and termination penalties.
When a lease liability is remeasured, an adjustment is made to the corresponding right-of use asset, or to profit or loss if the carrying
amount of the right-of-use asset is fully written down. |
| Provisions | Provisions Provisions are recognised when the consolidated
entity has a present (legal or constructive) obligation as a result of a past event, it is probable the consolidated entity will be required
to settle the obligation, and a reliable estimate can be made of the amount of the obligation. The amount recognised as a provision is
the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks
and uncertainties surrounding the obligation. If the time value of money is material, provisions are discounted using a current pre-tax
rate specific to the liability. The increase in the provision resulting from the passage of time is recognised as a finance cost. |
| Employee benefits | Employee benefits Short-term employee benefits Liabilities for wages and salaries, including
non-monetary benefits, annual leave and long service leave expected to be settled wholly within 12 months of the reporting date are measured
at the amounts expected to be paid when the liabilities are settled. Other long-term employee benefits The liability for annual leave and long service
leave not expected to be settled within 12 months of the reporting date are measured at the present value of expected future payments
to be made in respect of services provided by employees up to the reporting date using the projected unit credit method. Consideration
is given to expected future wage and salary levels, experience of employee departures and periods of service. Expected future payments
are discounted using market yields at the reporting date on high quality corporate bonds with terms to maturity and currency that match,
as closely as possible, the estimated future cash outflows. Share-based payments Equity-settled and cash-settled share-based compensation
benefits are provided to employees. Equity-settled transactions are awards of shares,
or options over shares, that are provided to employees in exchange for the rendering of services. Cash-settled transactions are awards
of cash for the exchange of services, where the amount of cash is determined by reference to the share price. The cost of equity-settled transactions are measured
at fair value on grant date. Fair value is independently determined using either the Binomial or Black-Scholes option pricing model that
takes into account the exercise price, the term of the option, the impact of dilution, the share price at grant date and expected price
volatility of the underlying share, the expected dividend yield and the risk free interest rate for the term of the option, together with
non-vesting conditions that do not determine whether the consolidated entity receives the services that entitle the employees to receive
payment. No account is taken of any other vesting conditions. The cost of equity-settled transactions are recognised
as an expense with a corresponding increase in equity over the vesting period. The cumulative charge to profit or loss is calculated based
on the grant date fair value of the award, the best estimate of the number of awards that are likely to vest and the expired portion of
the vesting period. The amount recognised in profit or loss for the period is the cumulative amount calculated at each reporting date
less amounts already recognised in previous periods. The cost of cash-settled transactions is initially,
and at each reporting date until vested, determined by applying either the Binomial or Black-Scholes option pricing model, taking into
consideration the terms and conditions on which the award was granted. The cumulative charge to profit or loss until settlement of the
liability is calculated as follows:
● during the vesting period, the liability at each reporting
date is the fair value of the award at that date multiplied by the expired portion of the vesting period.
● from the end of the vesting period until settlement of the
award, the liability is the full fair value of the liability at the reporting date. All changes in the liability are recognised in
profit or loss. The ultimate cost of cash-settled transactions is the cash paid to settle the liability. Market conditions are taken into consideration
in determining fair value. Therefore any awards subject to market conditions are considered to vest irrespective of whether or not that
market condition has been met, provided all other conditions are satisfied. If equity-settled awards are modified, as a minimum
an expense is recognised as if the modification has not been made. An additional expense is recognised, over the remaining vesting period,
for any modification that increases the total fair value of the share-based compensation benefit as at the date of modification. If the non-vesting condition is within the control
of the consolidated entity or employee, the failure to satisfy the condition is treated as a cancellation. If the condition is not within
the control of the consolidated entity or employee and is not satisfied during the vesting period, any remaining expense for the award
is recognised over the remaining vesting period, unless the award is forfeited. If equity-settled awards are cancelled, it is
treated as if it has vested on the date of cancellation, and any remaining expense is recognised immediately. If a new replacement award
is substituted for the cancelled award, the cancelled and new award is treated as if they were a modification. |
| Fair value measurement | Fair value measurement When an asset or liability, financial or non-financial,
is measured at fair value for recognition or disclosure purposes, the fair value is based on the price that would be received to sell
an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; and assumes that
the transaction will take place either: in the principal market; or in the absence of a principal market, in the most advantageous market. Fair value is measured using the assumptions that
market participants would use when pricing the asset or liability, assuming they act in their economic best interests. For non-financial
assets, the fair value measurement is based on its highest and best use. Valuation techniques that are appropriate in the circumstances
and for which sufficient data are available to measure fair value, are used, maximising the use of relevant observable inputs and minimising
the use of unobservable inputs. Assets and liabilities measured at fair value
are classified into three levels, using a fair value hierarchy that reflects the significance of the inputs used in making the measurements.
Classifications are reviewed at each reporting date and transfers between levels are determined based on a reassessment of the lowest
level of input that is significant to the fair value measurement. For recurring and non-recurring fair value measurements,
external valuers may be used when internal expertise is either not available or when the valuation is deemed to be significant. External
valuers are selected based on market knowledge and reputation. Where there is a significant change in fair value of an asset or liability
from one period to another, an analysis is undertaken, which includes a verification of the major inputs applied in the latest valuation
and a comparison, where applicable, with external sources of data. |
| Issued capital | Issued capital Ordinary shares are classified as equity. Incremental costs directly attributable to the
issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds. |
| Business combinations | Business combinations The acquisition method of accounting is used to
account for business combinations regardless of whether equity instruments or other assets are acquired. The consideration transferred is the sum of the
acquisition-date fair values of the assets transferred, equity instruments issued or liabilities incurred by the acquirer to former owners
of the acquiree and the amount of any non-controlling interest in the acquiree. For each business combination, the non-controlling interest
in the acquiree is measured at either fair value or at the proportionate share of the acquiree’s identifiable net assets. All acquisition
costs are expensed as incurred to profit or loss. On the acquisition of a business, the consolidated
entity assesses the financial assets acquired and liabilities assumed for appropriate classification and designation in accordance with
the contractual terms, economic conditions, the consolidated entity’s operating or accounting policies and other pertinent conditions
in existence at the acquisition-date. Where the business combination is achieved in
stages, the consolidated entity remeasures its previously held equity interest in the acquiree at the acquisition-date fair value and
the difference between the fair value and the previous carrying amount is recognised in profit or loss. Contingent consideration to be transferred by
the acquirer is recognised at the acquisition-date fair value. Subsequent changes in the fair value of the contingent consideration classified
as an asset or liability is recognised in profit or loss. Contingent consideration classified as equity is not remeasured and its subsequent
settlement is accounted for within equity. The difference between the acquisition-date fair
value of assets acquired, liabilities assumed and any non-controlling interest in the acquiree and the fair value of the consideration
transferred and the fair value of any pre-existing investment in the acquiree is recognised as goodwill. If the consideration transferred
and the pre-existing fair value is less than the fair value of the identifiable net assets acquired, being a bargain purchase to the acquirer,
the difference is recognised as a gain directly in profit or loss by the acquirer on the acquisition-date, but only after a reassessment
of the identification and measurement of the net assets acquired, the non-controlling interest in the acquiree, if any, the consideration
transferred and the acquirer’s previously held equity interest in the acquirer. Business combinations are initially accounted
for on a provisional basis. The acquirer retrospectively adjusts the provisional amounts recognised and also recognises additional assets
or liabilities during the measurement period, based on new information obtained about the facts and circumstances that existed at the
acquisition-date. The measurement period ends on either the earlier of (i) 12 months from the date of the acquisition or (ii) when the
acquirer receives all the information possible to determine fair value. |
| Earnings per share | Earnings per share Basic earnings per share Basic earnings per share is calculated by dividing
the profit attributable to the owners of Advanced Health Intelligence Ltd, excluding any costs of servicing equity other than ordinary
shares, by the weighted average number of ordinary shares outstanding during the financial year, adjusted for bonus elements in ordinary
shares issued during the financial year. Diluted earnings per share Diluted earnings per share adjusts the figures
used in the determination of basic earnings per share to take into account the after income tax effect of interest and other financing
costs associated with dilutive potential ordinary shares and the weighted average number of shares assumed to have been issued for no
consideration in relation to dilutive potential ordinary shares. |
| Goods and Services Tax (‘GST’) and other similar taxes | Goods and Services Tax (‘GST’) and other similar taxes Revenues, expenses and assets are recognised net
of the amount of associated GST, unless the GST incurred is not recoverable from the tax authority. In this case it is recognised as part
of the cost of the acquisition of the asset or as part of the expense. Receivables and payables are stated inclusive
of the amount of GST receivable or payable. The net amount of GST recoverable from, or payable to, the tax authority is included in other
receivables or other payables in the statement of financial position. Cash flows are presented on a gross basis. The
GST components of cash flows arising from investing or financing activities which are recoverable from, or payable to the tax authority,
are presented as operating cash flows. Commitments and contingencies are disclosed net
of the amount of GST recoverable from, or payable to, the tax authority. |
| New Accounting Standards and Interpretations not yet mandatory or early adopted | New Accounting Standards and Interpretations not yet mandatory
or early adopted Australian Accounting Standards and Interpretations
that have recently been issued or amended but are not yet mandatory, have not been early adopted by the consolidated entity for the annual
reporting period ended 30 June 2023. The consolidated entity has not yet assessed the impact of these new or amended Accounting Standards
and Interpretations. |
